Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
复制标题
DOI:
10.1016/j.immuni.2021.05.010
复制
发表时间:
2021-06-08
期刊:
影响因子:
32.4
通讯作者:
Smith KGC
中科院分区:
文献类型:
--
作者:
Bergamaschi L;Mescia F;Turner L;Hanson AL;Kotagiri P;Dunmore BJ;Ruffieux H;De Sa A;Huhn O;Morgan MD;Gerber PP;Wills MR;Baker S;Calero-Nieto FJ;Doffinger R;Dougan G;Elmer A;Goodfellow IG;Gupta RK;Hosmillo M;Hunter K;Kingston N;Lehner PJ;Matheson NJ;Nicholson JK;Petrunkina AM;Richardson S;Saunders C;Thaventhiran JED;Toonen EJM;Weekes MP;Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration;Göttgens B;Toshner M;Hess C;Bradley JR;Lyons PA;Smith KGC
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously assessed. Using immunophenotyping, RNA sequencing, and serum cytokine analysis, we analyzed serial samples from 207 SARS-CoV2-infected individuals with a range of disease severities over 12 weeks from symptom onset. An early robust bystander CD8+ T cell immune response, without systemic inflammation, characterized asymptomatic or mild disease. Hospitalized individuals had delayed bystander responses and systemic inflammation that was already evident near symptom onset, indicating that immunopathology may be inevitable in some individuals. Viral load did not correlate with this early pathological response but did correlate with subsequent disease severity. Immune recovery is complex, with profound persistent cellular abnormalities in severe disease correlating with altered inflammatory responses, with signatures associated with increased oxidative phosphorylation replacing those driven by cytokines tumor necrosis factor (TNF) and interleukin (IL)-6. These late immunometabolic and immune defects may have clinical implications. Longitudinal analysis of COVID-19 patients with a range of disease severity Early bystander CD8+ T cell and plasmablast responses characterize mild disease Pronounced systemic inflammation evident at first presentation in more severe COVID-19 Immune/inflammatory abnormalities persist in severe disease to 60 days post symptoms The immune changes that underlie COVID-19 severity have not been fully defined. By analyzing a longitudinal cohort of COVID-19 patients and integrating inflammatory factors, immunophenotyping, and transcriptome data, Bergamaschi et al. identify both early and persistent immune changes that distinguish mild and/or asymptomatic from more severe disease.
登录
查看更多内容
DOI:
10.1126/science.abd3072
发表时间:
2020-11-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Daly JL;Simonetti B;Klein K;Chen KE;Williamson MK;Antón-Plágaro C;Shoemark DK;Simón-Gracia L;Bauer M;Hollandi R;Greber UF;Horvath P;Sessions RB;Helenius A;Hiscox JA;Teesalu T;Matthews DA;Davidson AD;Collins BM;Cullen PJ;Yamauchi Y
通讯作者:
Yamauchi Y
影响因子:
20.3
作者:
Kamphuis, Elisabeth;Junt, Tobias;Kalinke, Ulrich
通讯作者:
Kalinke, Ulrich
影响因子:
5.8
作者:
Gu, Zuguang;Eils, Roland;Schlesner, Matthias
通讯作者:
Schlesner, Matthias
DOI:
10.1084/jem.20031051
发表时间:
2003-11-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Berg RE;Crossley E;Murray S;Forman J
通讯作者:
Forman J
影响因子:
30.5
作者:
Kaech, SM;Tan, JT;Ahmed, R
通讯作者:
Ahmed, R